http://www.cipla.com/
Cipla Limited is a pharmaceutical company based in Mumbai, India. Cipla makes drugs to treat cardiovascular disease, arthritis, diabetes, weight control, depression and many other health conditions.
On 31 March 2013, its market capitalisation was INR 305 billion (US$ 5.6 billion), making it India's 41st largest publicly traded company by market value.
It was founded by Dr. Khwaja Abdul Hamied as 'The Chemical, Industrial & Pharmaceutical Laboratories' in 1935 in Mumbai.
The name of the Company was changed to 'Cipla Limited' with effect from 20 July 1984, wherein the word Cipla came from the first letters of each word in the old name 'The Chemical, Industrial & Pharmaceutical Laboratories'.
In the year 1985, US FDA approved the company's bulk drug manufacturing facilities.
In 1994, Cipla launched Deferiprone, the world’s first oral iron chelator.
In 2001, Cipla offered medicines (antiretrovirals) for HIV treatment at a fractional cost (less than $350 per year per patient).
In 2012, the company slashed prices of three life-saving cancer drugs by 50-64%.
In 2013, it increased its stake in its South African joint venture CIPLA Medpro from 50% to 100% stake for INR 27 billion to strengthen its position in the African continent. Cipla Medpro is the third largest South African pharmaceutical company and it was founded in 1993.
Cipla Limited is a pharmaceutical company based in Mumbai, India. Cipla makes drugs to treat cardiovascular disease, arthritis, diabetes, weight control, depression and many other health conditions.
On 31 March 2013, its market capitalisation was INR 305 billion (US$ 5.6 billion), making it India's 41st largest publicly traded company by market value.
It was founded by Dr. Khwaja Abdul Hamied as 'The Chemical, Industrial & Pharmaceutical Laboratories' in 1935 in Mumbai.
The name of the Company was changed to 'Cipla Limited' with effect from 20 July 1984, wherein the word Cipla came from the first letters of each word in the old name 'The Chemical, Industrial & Pharmaceutical Laboratories'.
In the year 1985, US FDA approved the company's bulk drug manufacturing facilities.
In 1994, Cipla launched Deferiprone, the world’s first oral iron chelator.
In 2001, Cipla offered medicines (antiretrovirals) for HIV treatment at a fractional cost (less than $350 per year per patient).
In 2012, the company slashed prices of three life-saving cancer drugs by 50-64%.
In 2013, it increased its stake in its South African joint venture CIPLA Medpro from 50% to 100% stake for INR 27 billion to strengthen its position in the African continent. Cipla Medpro is the third largest South African pharmaceutical company and it was founded in 1993.